All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Moderna Therapeutics emerged from stealth mode with a $40 million financing led by Flagship Ventures and a consortium of private investors. Moderna is developing a platform technology for delivery of messenger RNA (mRNA) to stimulate production of therapeutic proteins in the cells.